ArticleBiomedicines2023

Comparison of Efficacy and Safety of Anti-Programmed Cell Death-1 Antibody Plus Lenvatinib and Chemotherapy as First-Line Therapy for Patients with Stage IV Gallbladder Cancer: A Real-World Study in a Chinese Population.

Tiantian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.